The ability of macrophages to kill many bacterial species is augmented by IFNγ treatment, and both mice and humans who lack proper IFNγ activity are susceptible to recurrent and sometimes fatal bacterial infections [31–34]. Here, IFNG is linked to bacterial infectious disease.